Clinical Trials Logo

Filter by:
NCT ID: NCT04206566 Completed - Intubation Clinical Trials

Pre-hospital Advanced Airway Management Studying Expedited Routines

PHASTER
Start date: March 1, 2020
Phase:
Study type: Observational

In the Scandinavian and Swiss HEMS critical care teams, the prehospital tracheal intubations (TI) are performed by airway experts with high success rates and low rates of complications. Due to environmental conditions these are today frequently performed in-cabin before take-off. There are so far no published data on comparing outside and in-cabin TI under these circumstances. This will therefore be the first prospective study comparing prehospital TIs outside or incabin, performed by airway experts.

NCT ID: NCT04203784 Completed - Sepsis Clinical Trials

Meropenem and Piperacillin Plasma Concentrations During CRRT

ABC2
Start date: November 1, 2012
Phase:
Study type: Observational

This observational study reports meropenem and piperacillin plasma concentrations in patients treated with either antibiotic and simultaneous continuous renal replacement therapy (CRRT).

NCT ID: NCT04203758 Completed - Obesity Clinical Trials

High Fiber Rye Foods for Body Weight and Body Fat Reduction

RyeWeight2
Start date: January 20, 2020
Phase: N/A
Study type: Interventional

The overall aim of this study is to investigate whether a diet rich in rye fiber from wholegrain rye, compared to refined wheat, as part of a hypo-caloric diet leads to larger weight loss and lower body fat content after 12 weeks of intervention.

NCT ID: NCT04201509 Completed - Clinical trials for Attention Deficit Hyperactivity Disorder

Validity of Neurocognitive Assessment Methods in Childhood ADHD

Start date: June 1, 2011
Phase:
Study type: Observational

The aim of the study is to examine the prospective validity of neurocognitive functions and emotional factors in schoolchildren with ADHD and a control group of typically developing schoolchildren at baseline and after three years.

NCT ID: NCT04190693 Completed - Clinical trials for Type 1 Diabetes Mellitus

IMCY-T1D-002: Long-term Follow-up Study of T1D Patients Previously Treated With IMCY-0098 or Placebo

IMCY-T1D-002
Start date: February 14, 2019
Phase: Phase 1
Study type: Interventional

This study is the follow-up of study IMCY-T1D 001 (EudraCT: 2016-003514-27, NCT03272269) in which patients with recent onset T1D have been treated with IMCY-0098 or placebo. At the end of the primary 6 month study, patients will be proposed to enter this follow-up study to evaluate up to 12 months (V3 - Week 48) the safety, the immune responses and the clinical parameters. The study involves a follow-up of 6 months after the end of the initial participation to the IMCY-T1D-001 study. Subjects will undergo visits at 24 weeks, 36 weeks and 48 weeks post first study product administration in study IMCY-T1D-001. For each patient, the study comprises a total of 3 visits occurring over a period of approximately 24 weeks (from study entry). The patients will undergo planned assessments and procedures as outlined in the table of study procedures.

NCT ID: NCT04190147 Completed - Preterm Birth Clinical Trials

Eye and Growth in Adolescents Born Moderate-to-late Preterm

Start date: October 28, 2019
Phase:
Study type: Observational

During recent years, the interest in studying the risks of being born moderate-to-late preterm (MLP), defined as birth between gestational week 32 to 36, has increased. Today the investigators know that morbidity and mortality are significantly higher in these individuals compared to individuals born full-term. However, few studies have focused on the development of the eye in MLP individuals. The purpose of the study is to evaluate eye morphology and visual function in relation to growth, metabolism, blood pressure, neuropsychiatric factors, and quality of life in adolescents born MLP. The results of the examinations will be compared to an age-matched control group. The study will evaluate the structural, functional, and metabolic aspects of the eye with the hypothesis that early eye abnormalities may detect the risk of developing metabolic and cardiovascular diseases.

NCT ID: NCT04188964 Completed - Clinical trials for X-linked Hypophosphatemia (XLH)

Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Patients Less Than 1 Year of Age

Start date: February 26, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

A Phase 1/2, Open-label, Multicenter, Non-randomized Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Paediatric Patients from Birth to Less than 1 Year of Age with X-linked Hypophosphatemia (XLH)

NCT ID: NCT04182178 Completed - Dysphagia Clinical Trials

Long-term Follow-up After Surgical Treatment for GERD (Gastroesophageal Reflux Disease)

Start date: August 5, 2019
Phase:
Study type: Observational

10 years of follow-up with SF-36 global (Quality of Life issues), GSRS (Gastrointestinal Symptom Rating Scale) and two reflux specific questionnaires.

NCT ID: NCT04180189 Completed - Adhd Clinical Trials

An Intervention With Weighted Blankets for Children With ADHD and Sleep Problems

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

The aim of the study is to evaluate a sleep intervention with weighted blankets for children with ADHD and sleep problem regarding health-related outcomes, sleep, and cost-effectiveness. The study is an RCT with cross-over design. The participants will be randomized to start with an active or placebo blanket, and then change blankets during the 16 week study period.

NCT ID: NCT04175457 Completed - Thrombosis Clinical Trials

The Acute Effects of E-cigarette Inhalation on Vascular Function, Microcirculation and Thrombosis

Start date: December 5, 2019
Phase: N/A
Study type: Interventional

This is a human randomized controlled cross-over study where the effects of e-cigarette inhalation (with or without nicotine) on vascular function, microcirculation and thrombosis is assessed.